Angel Biotechnology Holdings Plc Statement re. Suspension (5027X)
08 Februar 2013 - 1:53PM
UK Regulatory
TIDMABH
RNS Number : 5027X
Angel Biotechnology Holdings Plc
08 February 2013
8 February 2013
Angel Biotechnology Holdings plc
("Angel" or "the Company")
Statement regarding suspension
On 28 January 2013, the Company advised announced that Company
needed to enter into a strategic relationship with another party to
develop more effectively its contract manufacturing business and
that it had for some time been in discussions with a consortium of
overseas organisations in this connection. The Company also stated
that in the opinion of the Board, this arrangement was essential to
the ongoing viability of the Company.
The Company regrets to announce that discussions with that
consortium have been terminated and requested an immediate
suspension of trading in its Ordinary Shares on AIM pending
clarification of its financial position.
In view of its trading difficulties, the Company intends to
appoint administrators and a further announcement will be made as
appropriate.
For further information:
Angel Biotechnology Holdings plc
Nicholas Smith, Non-Executive Chairman +44 (0) 131 445 6077
www.angelbio.com
Grant Thornton, Corporate Finance
Colin Aaronson / Melanie Frean +44 (0) 20 7383 5100
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSSSEFEAFDSEIE
Angel Biotechnology (LSE:ABH)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Angel Biotechnology (LSE:ABH)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
Echtzeit-Nachrichten über Angel Biotech (Londoner Börse): 0 Nachrichtenartikel
Weitere Angel Biotechnology News-Artikel